Justin Eyquem, PhD, is Scientific Co-Founder and Scientific Advisor at Mnemo. Justin has extensive research experience in cancer immunotherapy, with research interests including genome editing, CAR T cell immunology, and developing novel CAR designs that recognize low tumor antigen density. He previously worked in Michel Sadelain’s lab at MSKCC to engineer CAR T cells using CRISPR/Cas9. In 2019, Justin was honored with the Parker Fellow Award and opened the Eyquem Lab in the department of Microbiology and Immunology at the University of California, San Francisco. At his lab, he is developing a gene editing platform to enhance CAR T and NK cell functions in hematological and solid tumors. Justin earned his PhD from the University of Paris-Diderot in collaboration with the biotech company Cellectis.